Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
8 Patents
#21 in Brisbane, CA
#8,545 in California
#35,954 in US
Arch Oncology, Inc.
Forward Citations = 35
11 inventors:
Brisbane, CA, United States of America
Arch Oncology, Inc.
Calculating rank
% Expired Patents = 25.0
EPO Patents = 1
Forward Citations = 35
Loading Chart...
Loading Chart...
11 inventors (with patents filed for the assignee):
Pamela T Manning (7 out of 10 patents)
Hwai Wen Chang (4 out of 58 patents)
Gerhard Johann Frey (4 out of 87 patents)
4. William A Frazier (4 out of 14 patents)
5. Robyn Puro (4 out of 4 patents)
6. Juan C Almagro (4 out of 29 patents)
7. Robert W Karr (4 out of 5 patents)
8. Ronald R Hiebsch (1 out of 1 patent)
9. Benjamin J Capoccia (1 out of 1 patent)
10. Gabriela Andrejeva (1 out of 1 patent)
11. Daniel S Pereira (1 out of 1 patent)
8 patents:
Company Overview
Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody-based therapeutics for the treatment of solid tumors. The company's lead product candidate, AO-176, is being evaluated in multiple clinical trials for various cancer indications.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arch Oncology, Inc.. Retrieved from https://idiyas.com/company/arch-oncology
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]